Cargando…

Therapeutic drug monitoring of docetaxel by pharmacokinetics and pharmacogenetics: A randomized clinical trial of AUC‐guided dosing in nonsmall cell lung cancer

Detalles Bibliográficos
Autores principales: Ma, Yuxiang, Zhao, Xin, Chen, Xi, Huang, Xinxin, Lin, Qingguang, Lin, Yuehao, Salamone, Salvatore J, Zhou, Xinlan, Wang, Changzheng, Liang, Weiting, Zhao, Hongyun, Wu, Kui, Yang, Yunpeng, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021539/
https://www.ncbi.nlm.nih.gov/pubmed/33931979
http://dx.doi.org/10.1002/ctm2.354
_version_ 1783674767032713216
author Ma, Yuxiang
Zhao, Xin
Chen, Xi
Huang, Xinxin
Lin, Qingguang
Lin, Yuehao
Salamone, Salvatore J
Zhou, Xinlan
Wang, Changzheng
Liang, Weiting
Zhao, Hongyun
Wu, Kui
Yang, Yunpeng
Zhang, Li
author_facet Ma, Yuxiang
Zhao, Xin
Chen, Xi
Huang, Xinxin
Lin, Qingguang
Lin, Yuehao
Salamone, Salvatore J
Zhou, Xinlan
Wang, Changzheng
Liang, Weiting
Zhao, Hongyun
Wu, Kui
Yang, Yunpeng
Zhang, Li
author_sort Ma, Yuxiang
collection PubMed
description
format Online
Article
Text
id pubmed-8021539
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80215392021-04-08 Therapeutic drug monitoring of docetaxel by pharmacokinetics and pharmacogenetics: A randomized clinical trial of AUC‐guided dosing in nonsmall cell lung cancer Ma, Yuxiang Zhao, Xin Chen, Xi Huang, Xinxin Lin, Qingguang Lin, Yuehao Salamone, Salvatore J Zhou, Xinlan Wang, Changzheng Liang, Weiting Zhao, Hongyun Wu, Kui Yang, Yunpeng Zhang, Li Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-04-05 /pmc/articles/PMC8021539/ /pubmed/33931979 http://dx.doi.org/10.1002/ctm2.354 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Ma, Yuxiang
Zhao, Xin
Chen, Xi
Huang, Xinxin
Lin, Qingguang
Lin, Yuehao
Salamone, Salvatore J
Zhou, Xinlan
Wang, Changzheng
Liang, Weiting
Zhao, Hongyun
Wu, Kui
Yang, Yunpeng
Zhang, Li
Therapeutic drug monitoring of docetaxel by pharmacokinetics and pharmacogenetics: A randomized clinical trial of AUC‐guided dosing in nonsmall cell lung cancer
title Therapeutic drug monitoring of docetaxel by pharmacokinetics and pharmacogenetics: A randomized clinical trial of AUC‐guided dosing in nonsmall cell lung cancer
title_full Therapeutic drug monitoring of docetaxel by pharmacokinetics and pharmacogenetics: A randomized clinical trial of AUC‐guided dosing in nonsmall cell lung cancer
title_fullStr Therapeutic drug monitoring of docetaxel by pharmacokinetics and pharmacogenetics: A randomized clinical trial of AUC‐guided dosing in nonsmall cell lung cancer
title_full_unstemmed Therapeutic drug monitoring of docetaxel by pharmacokinetics and pharmacogenetics: A randomized clinical trial of AUC‐guided dosing in nonsmall cell lung cancer
title_short Therapeutic drug monitoring of docetaxel by pharmacokinetics and pharmacogenetics: A randomized clinical trial of AUC‐guided dosing in nonsmall cell lung cancer
title_sort therapeutic drug monitoring of docetaxel by pharmacokinetics and pharmacogenetics: a randomized clinical trial of auc‐guided dosing in nonsmall cell lung cancer
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021539/
https://www.ncbi.nlm.nih.gov/pubmed/33931979
http://dx.doi.org/10.1002/ctm2.354
work_keys_str_mv AT mayuxiang therapeuticdrugmonitoringofdocetaxelbypharmacokineticsandpharmacogeneticsarandomizedclinicaltrialofaucguideddosinginnonsmallcelllungcancer
AT zhaoxin therapeuticdrugmonitoringofdocetaxelbypharmacokineticsandpharmacogeneticsarandomizedclinicaltrialofaucguideddosinginnonsmallcelllungcancer
AT chenxi therapeuticdrugmonitoringofdocetaxelbypharmacokineticsandpharmacogeneticsarandomizedclinicaltrialofaucguideddosinginnonsmallcelllungcancer
AT huangxinxin therapeuticdrugmonitoringofdocetaxelbypharmacokineticsandpharmacogeneticsarandomizedclinicaltrialofaucguideddosinginnonsmallcelllungcancer
AT linqingguang therapeuticdrugmonitoringofdocetaxelbypharmacokineticsandpharmacogeneticsarandomizedclinicaltrialofaucguideddosinginnonsmallcelllungcancer
AT linyuehao therapeuticdrugmonitoringofdocetaxelbypharmacokineticsandpharmacogeneticsarandomizedclinicaltrialofaucguideddosinginnonsmallcelllungcancer
AT salamonesalvatorej therapeuticdrugmonitoringofdocetaxelbypharmacokineticsandpharmacogeneticsarandomizedclinicaltrialofaucguideddosinginnonsmallcelllungcancer
AT zhouxinlan therapeuticdrugmonitoringofdocetaxelbypharmacokineticsandpharmacogeneticsarandomizedclinicaltrialofaucguideddosinginnonsmallcelllungcancer
AT wangchangzheng therapeuticdrugmonitoringofdocetaxelbypharmacokineticsandpharmacogeneticsarandomizedclinicaltrialofaucguideddosinginnonsmallcelllungcancer
AT liangweiting therapeuticdrugmonitoringofdocetaxelbypharmacokineticsandpharmacogeneticsarandomizedclinicaltrialofaucguideddosinginnonsmallcelllungcancer
AT zhaohongyun therapeuticdrugmonitoringofdocetaxelbypharmacokineticsandpharmacogeneticsarandomizedclinicaltrialofaucguideddosinginnonsmallcelllungcancer
AT wukui therapeuticdrugmonitoringofdocetaxelbypharmacokineticsandpharmacogeneticsarandomizedclinicaltrialofaucguideddosinginnonsmallcelllungcancer
AT yangyunpeng therapeuticdrugmonitoringofdocetaxelbypharmacokineticsandpharmacogeneticsarandomizedclinicaltrialofaucguideddosinginnonsmallcelllungcancer
AT zhangli therapeuticdrugmonitoringofdocetaxelbypharmacokineticsandpharmacogeneticsarandomizedclinicaltrialofaucguideddosinginnonsmallcelllungcancer